Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dermtech Inc (NQ: DMTK )

2.470 +0.010 (+0.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 222,564
Open 2.430
Bid (Size) 2.400 (1)
Ask (Size) 2.560 (1)
Prev. Close 2.460
Today's Range 2.430 - 2.548
52wk Range 1.550 - 8.930
Shares Outstanding 29,940,637
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
DermTech Earnings Perspective: Return On Capital Employed
 
Via Benzinga
DermTech Announces Agreements With South Carolina Blues Plan and the United Mine Workers of America Health and Retirement Funds for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire

Performance

YTD
+35.71%
+35.71%
1 Month
-14.53%
-14.53%
3 Month
-33.24%
-33.24%
6 Month
-5.36%
-5.36%
1 Year
-62.80%
-62.80%

More News

Read More
DermTech Grants New CEO Bret Christensen Inducement Award Under NASDAQ Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech Appoints Bret Christensen as New President and CEO
From DermTech, Inc.
Via Business Wire
Recap: DermTech Q1 Earnings
Via Benzinga
DermTech's Return On Capital Employed Overview
Via Benzinga
Nasdaq Surges Over 2%; Fluor Posts Downbeat Earnings
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Rises Sharply; Johnson Controls Earnings Beat Views
Via Benzinga
Dow Jumps 400 Points; US Economy Adds 253,000 Jobs In April
Via Benzinga
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
DermTech Reports First-Quarter 2023 Financial Results
From DermTech, Inc.
Via Business Wire
New Survey Data Reveals Nearly 75% of Consumers Have Not Had a Full Skin Exam Within the Past 12 Months
From DermTech, Inc.
Via Business Wire
DermTech Announces Contract With New York Health Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
DermTech, Inc. (NASDAQ:DMTK) Investor Notice: Investigation over Possible Violations of Securities Laws
Via SBWire
DermTech Announces Release Date for First-quarter 2023 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Announces Contract With North Carolina Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
New Survey Finds Millennials and Gen Xers Not Following Safe Sun Habits, Increasing Risk of Nonmelanoma Skin Cancer
From DermTech, Inc.
Via Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech to Present Four New Posters and Demonstrate its Smart Stickers™ at the 2023 American Academy of Dermatology (AAD) Annual Meeting
From DermTech, Inc.
Via Business Wire
DermTech Adds Approximately 1.9 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
From DermTech, Inc.
Via Business Wire
Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday
Via Benzinga
Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
DermTech to Present at March Investor Conferences
From DermTech, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.